Home Overview Press Room Blog Publications For Students about us
Search

About Global Governance & Human Biotechnology


Several important international bodies have adopted human biotechnology policies, though most regulation takes place at the national level.

International organizations have taken strong stands to prevent human reproductive cloning and inheritable genetic modification. The Council of Europe's Convention on Human Rights and Biomedicine (1997)—the most authoritative international agreement to date—bans inheritable genetic modification, human reproductive cloning, and research cloning while also regulating other human biotechnologies.

UNESCO, the European Parliament, the Group of Eight industrial nations, the World Health Assembly, and the United Nations have also adopted various prohibitions on human reproductive cloning.



God’s Red Pencil? CRISPR and The Three Myths of Precise Genome Editingby Jonathan LathamIndependent Science NewsApril 25th, 2016CRISPR is the latest platform in a 70-year-old "gospel of precision" used to justify moving quickly with new chemical and biological technologies, despite decades of disasters and unintended consequences.
Save the Mosquitosby Ashley DawsonJacobinApril 22nd, 2016We should fight Zika with better public health, not genetically modified mosquitos.
Kuwait Becomes First Country to Collect DNA Samples From All Citizens and Visitors: Reportby Seung LeeNewsweekApril 19th, 2016Kuwait will use mobile centers to collect samples from citizens, and take cheek swabs at airports on all visitors; anyone faking DNA samples faces up to seven years in prison.
Gene-editing research in human embryos gains momentumby Ewen CallawayNature NewsApril 19th, 2016Experiments are now approved in Sweden, China and the United Kingdom.
CRISPR: Pursuit of profit poisons collaborationby Jacob S. SherkowNature April 13th, 2016Overzealous efforts to commercialize technology can damage science.
The Scientific Swap Meet Behind the Gene-Editing Boomby Antonio RegaladoMIT Technology ReviewApril 8th, 2016"Amazon.com for biological parts," AddGene non-profit in Cambridge ships CRISPR-Cas9 parts all over the world. “It dramatically sped up CRISPR adoption."
10th Anniversary Baby Markets Congressby Elliot HosmanApril 7th, 2016Legal scholars, social scientists, advocates, and filmmakers grapple with assisted reproduction.
The Surrogacy Cycleby Abby RabinowitzThe Virginia Quarterly ReviewMarch 31st, 2016Promising an escape from poverty, transnational surrogacy has left many Indian women with little to show for their efforts. What went wrong?
CRISPR Pioneer Feng Zhang Talks About What's Next for Gene Editingby Kate LunauVICE MotherboardMarch 23rd, 2016“The field is still very young,” but Zhang hopes CRISPR is a way to address conditions that he characterizes as psychiatric, including depression, schizophrenia, autism and Alzheimer’s.
Are We Ready For Designer Babies?by Claire MaldarelliPopular ScienceMarch 21st, 2016The CRISPR gene editing debate can’t just occur within the walls of a conference center. As its power comes into focus, public discussion should proceed in tandem.
Displaying 1-10 of 356  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760